Cancer
-
BusinessCancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
NewsMacArthur ‘genius’ fellowships recognise biophysicist and analytical chemist
Foundation awards ‘no strings’ grants for cellular compartmentalisation and cancer surgery research
-
NewsImmune-stimulating cancer treatment takes 2018 medicine Nobel
James Allison and Tasuku Honjo receive science’s highest honour for discovering how cancer stops immune cells from attacking
-
ResearchSimple test behind early cancer diagnosis breakthrough
Technique combines rolling circle amplification with time-gated Förster resonance energy transfer to detect cancer microRNA
-
BusinessLandmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
NewsFood agency wades into Californian coffee cancer labels controversy
US body speaks out against ruling that may force cancer warnings on coffee sold in the state due to acrylamide
-
BusinessEurope opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
-
ResearchArtificial intelligence seeks out new anticancer drugs
A combination of machine learning methods yields promising results for drug discovery
-
BusinessJ&J hit with bill for $4.7 billion in damages over talcum powder cancer link
Pharmaceutical and consumer goods giant loses another talc court case to 22 ovarian cancer patients
-
BusinessJ&J and the question of shadow research
Former academic researcher who found that talc is not carcinogenic admits that J&J funded his work, but says that fact is immaterial
